interRAI’s 1st generation QI set [37] | Swiss RAI-HC QI set [29] | interRAI’s 2nd generation QI set [30] | |
---|---|---|---|
Domain 1: Purpose, relevance and organizational context | 60% | 60% | 47% |
The purpose of the indicator is described clearly | 4 | 4 | 3.5 |
The criteria for selecting the topic of the indicator are described in detail | 2.5 | 4 | 3 |
The organizational context of the indicator is described in detail | 4 | 3.5 | 2 |
The quality domain the indicator addresses is described in detail | 2.5 | 1.5 | 2.5 |
The health-care process covered by the indicator is described and defined in detail | 1 | 1 | 1 |
Domain 2: Stakeholder Involvement | 44% | 28% | 56% |
The group developing the indicator includes individuals from relevant professional groups | 3.5 | 2.5 | 4 |
Considering the purpose of the indicator, all relevant stakeholders have been involved at some stage of the development process | 2.5 | 2 | 3 |
The indicator has been formally endorsed | 1 | 1 | 1 |
Domain 3: Scientific evidence | 11% | 0% | 0% |
Systematic methods were used to search for scientific evidence | 1.5 | 1 | 1 |
The indicator is based on recommendations from an evidence-based guideline | 1.5 | 1 | 1 |
The supporting evidence has been critically appraised | 1 | 1 | 1 |
Domain 4: Additional evidence, formulation and usage | 69% | 48% | 54% |
The numerator and denominator are described in detail | 4 | 4 | 4 |
The target patient population of the indicator is defined clearly | 4 | 2 | 2 |
A strategy for risk adjustment has been considered and described | 4 | 1 | 4 |
The indicator measures what it is intended to measure (validity) | 2.5 | 2.5 | 2.5 |
The indicator measures accurately and consistently (reliability) | 1 | 3.5 | 1 |
The indicator has sufficient discriminative power | 3.5 | 3 | 3.5 |
The indicator has been piloted in practice | 1 | 1 | 1 |
The efforts needed for data collection have been considered | 4 | 4 | 4 |
Specific instructions for presenting and interpreting the indicator results are provided | 3.5 | 1 | 1.5 |